The study and its comparison
Twenty-four men with mild erectile dysfunction completed a single-blind study. They received placebo for one month followed by citrulline for another month, with erection-hardness and sexual-activity measures recorded. [1]
Twelve men reached the study’s normal-hardness category during citrulline treatment, compared with two during placebo. No adverse events were reported in this small cohort. [1]
What the finding establishes
The fixed sequence leaves time and order effects unresolved; it was not a randomized parallel comparison. Twenty-four participants cannot establish comprehensive safety or equivalence to established therapies. Funding and conflicts were not established from the abstract. Citrulline is a different compound from creatine, so this pilot supplies no evidence that creatine treats erectile dysfunction. [1]
A hypothetical distinction
Imagine everyone receives active treatment second. Improvement may reflect treatment, time, expectations or a combination that the design cannot fully separate.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.